These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6408713)

  • 1. Factors affecting the termination of cardiovascular actions of 10,10-difluoro,13-dehydroprostacyclin.
    Powell JR; Kerwin LJ; McGill MH; Haslanger M; Fried J
    Prostaglandins; 1983 Mar; 25(3):457-67. PubMed ID: 6408713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin.
    Hatano Y; Kohli JD; Goldberg LI; Fried J; Mehrotra MM
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6846-50. PubMed ID: 7005902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of prostaglandins E2 and I2 on rat renal vascular resistance.
    Baer PG; McGiff JC
    Eur J Pharmacol; 1979 Mar; 54(4):359-63. PubMed ID: 374096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 13, 14-dehydroprostacyclin methyl ester on the feline intestinal vascular bed.
    Paustian PW; Chapnick BM; Feigen LP; Hyman AL; Kadowitz PJ
    Prostaglandins; 1977; 14(6):1141-52. PubMed ID: 341229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.
    Hyman AL; Kadowitz PJ
    Circ Res; 1979 Sep; 45(3):404-9. PubMed ID: 110490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostacyclin on hepatic vasculature and metabolism of renin in conscious dogs.
    Echtenkamp SF; Davis JO; Freeman RH; Dietz JR; Villarreal D
    Am J Physiol; 1982 Oct; 243(4):H584-9. PubMed ID: 6751098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin effects on renal hemodynamic and excretory functions in the rat.
    Baer PG; Kauker ML; McGiff JC
    J Pharmacol Exp Ther; 1979 Feb; 208(2):294-7. PubMed ID: 368314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular actions of prostacyclin (PGI2) in the cat.
    Lippton HL; Paustian PW; Mellion BT; Nelson PK; Feigen LP; Chapnick BM; Hyman AL; Kadowitz PJ
    Arch Int Pharmacodyn Ther; 1979 Sep; 241(1):121-30. PubMed ID: 393193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prostacyclin on vascular capacity in the dog.
    Fulghum TG; DiMarco JP; Supple EW; Nash I; Gendlerman J; Eton DF; Newell JB; Zusman RM; Powell WJ
    J Clin Invest; 1985 Sep; 76(3):999-1006. PubMed ID: 3930573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of prostaglandins in peripheral vascular beds.
    Feigen LP
    Fed Proc; 1981 May; 40(7):1987-90. PubMed ID: 7014257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic responses to prostacyclin (PGI2) in the conscious sheep.
    Kubo K; Kobayashi T; Yoshimura K; Fukushima M; Handa K; Kusama S; Sakai A; Ueda G
    Jpn Circ J; 1982 Dec; 46(12):1292-304. PubMed ID: 6754986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between prostacyclin and nitric oxide in the reflex control of the coronary circulation in conscious dogs.
    Zhao G; Xu X; Ochoa M; Shen W; Hintze TH
    Cardiovasc Res; 1996 Nov; 32(5):940-8. PubMed ID: 8944825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vasodilator activity of 13,14-dehydroprostacyclin methyl ester: comparison with prostacyclin and other prostanoids.
    Hyman AL; Kadowitz PJ; Lands WE; Crawford CG; Fried J; Barton J
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3522-6. PubMed ID: 356056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of prostaglandin I2 and E2 on renal hemodynamics and function and renin release.
    Imanishi M; Abe Y; Okahara T; Yukimura T; Yamamoto K
    Jpn Circ J; 1980 Nov; 44(11):875-82. PubMed ID: 7001085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal haemodynamic and excretory actions of prostacyclin and 6-oxo-PGF1 alpha in anaesthetized dogs.
    Hill TW; Moncada S
    Prostaglandins; 1979 Jan; 17(1):87-98. PubMed ID: 375317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of PGE2 and PGI2 in salt-loaded and salt-depleted dogs.
    Watson ML; Jones RL
    Adv Prostaglandin Thromboxane Res; 1980; 7():1057-60. PubMed ID: 6989176
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular responses to PGI2 (prostacyclin) in the dog.
    Fitzpatrick TM; Alter I; Corey EJ; Ramwell PW; Rose JC; Kot PA
    Circ Res; 1978 Feb; 42(2):192-4. PubMed ID: 340081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of prostacyclin prevents ventricular fibrillation following coronary occlusion in conscious dogs.
    Starnes VA; Primm RK; Woosley RL; Oates JA; Hammon JW
    J Cardiovasc Pharmacol; 1982; 4(5):765-9. PubMed ID: 6182407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of PGI2 on canine renal function and hemodynamics.
    Gerber JG; Nies AS; Friesinger GC; Gerkens JF; Branch RA; Oates JA
    Prostaglandins; 1978 Oct; 16(4):519-28. PubMed ID: 364549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prostaglandin E2, I2 and F2 alpha on systemic and renal hemodynamics, renal function and renin secretion in anesthetized dogs.
    Hashimoto T
    Jpn J Pharmacol; 1980 Apr; 30(2):173-86. PubMed ID: 7005498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.